Protocol Ledger

NCT05625932 · Phase III · COMPLETED

TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer

Interventional Phase III clinical trial protocol NCT05625932 sponsored by Galician Research Group on Digestive Tumors in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2023-03-02 Enrollment: 232 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05625932
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)232 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05625932
Protocol FieldVerified Registry Value
NCT IdentifierNCT05625932
Consolidated Lead SponsorGalician Research Group on Digestive Tumors
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment232 participants (ACTUAL)
Registered Start Date2023-03-02
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT05625932
Hospital Research SiteLocationSite Profile
Hospital Universitario Marqués de ValdecillaSantander, SpainOpen Hospital Dossier ->
Hospital de La Santa Creu I Sant PauBarcelona, SpainOpen Hospital Dossier ->
Hospital Clinic BarcelonaBarcelona, SpainOpen Hospital Dossier ->
Hospital Clinico San CarlosMadrid, SpainOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI